Form 8-K - Current report:
SEC Accession No. 0002008861-25-000019
Filing Date
2025-06-25
Accepted
2025-06-25 17:15:14
Documents
12
Period of Report
2025-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ndoi-20250625.htm   iXBRL 8-K 48351
  Complete submission text file 0002008861-25-000019.txt   153269

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ndoi-20250625.xsd EX-101.SCH 1845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ndoi-20250625_lab.xml EX-101.LAB 19410
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ndoi-20250625_pre.xml EX-101.PRE 11035
14 EXTRACTED XBRL INSTANCE DOCUMENT ndoi-20250625_htm.xml XML 2424
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 251074482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)